| DGRE | EMXC | DGRE / EMXC | |
| Gain YTD | 34.086 | 39.955 | 85% |
| Net Assets | 150M | 25.2B | 1% |
| Total Expense Ratio | 0.32 | 0.25 | 128% |
| Turnover | 22.00 | 15.00 | 147% |
| Yield | 1.27 | 1.96 | 65% |
| Fund Existence | 13 years | 9 years | - |
| DGRE | EMXC | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 72% | 6 days ago 76% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 87% | 2 days ago 82% |
| MACD ODDS (%) | 4 days ago 82% | 3 days ago 84% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 84% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 83% |
| Advances ODDS (%) | 2 days ago 81% | 2 days ago 83% |
| Declines ODDS (%) | about 1 month ago 76% | about 1 month ago 77% |
| BollingerBands ODDS (%) | 2 days ago 73% | 2 days ago 77% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 82% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IPOAX | 26.34 | 0.07 | +0.27% |
| Nomura Systematic Emerging Markets Eq A | |||
| UUPIX | 80.50 | N/A | N/A |
| ProFunds UltraEmerging Markets Inv | |||
| SHSCX | 49.04 | N/A | N/A |
| BlackRock Health Sciences Opps Inv C | |||
| SSRRX | 7.89 | N/A | N/A |
| Touchstone Small Company R6 | |||
| APSDX | 18.67 | -0.07 | -0.37% |
| NYLIM Fiera SMID Growth Class R6 | |||